Adaptimmune Therapeutics Plc Financial Flexibility Index
Adaptimmune Therapeutics Plc financial flexibility index. Adaptimmune Therapeutics Plc (ADAP) has a Financial Flexibility Index of -0.17x as of June 2025. Free cash flow of $-34.70 Million (operating CF $-34.78 Million minus capex $75.00K) represents 0% of total liabilities ($201.59 Million). See ADAP free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Adaptimmune Therapeutics Plc (2012–2024)
Financial flexibility index of Adaptimmune Therapeutics Plc from 2012 to 2024. Historical Financial Flexibility Index trend for Adaptimmune Therapeutics Plc across 13 annual periods. Check ADAP cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Adaptimmune Therapeutics Plc Financial Flexibility Index by Year (2012–2024)
Adaptimmune Therapeutics Plc financial flexibility index by year from 2012 to 2024. Year-by-year free cash flow to debt coverage for Adaptimmune Therapeutics Plc. For the full cash flow conversion analysis, see Adaptimmune Therapeutics Plc cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.30x | $-70.49 Million | $-73.21 Million | $234.11 Million | ▲ +46.2% |
| 2023 | -0.56x | $-136.00 Million | $-140.88 Million | $243.10 Million | ▼ -23.4% |
| 2022 | -0.45x | $-112.03 Million | $-141.77 Million | $247.04 Million | ▼ -712.7% |
| 2021 | 0.07x | $19.51 Million | $10.73 Million | $263.58 Million | ▲ +116.1% |
| 2020 | -0.46x | $-50.69 Million | $-53.59 Million | $109.92 Million | ▲ +75.6% |
| 2019 | -1.89x | $-109.43 Million | $-112.51 Million | $57.91 Million | ▲ +43.4% |
| 2018 | -3.34x | $-99.68 Million | $-104.39 Million | $29.85 Million | ▼ -790.7% |
| 2017 | -0.37x | $-29.30 Million | $-54.31 Million | $78.16 Million | ▲ +27.6% |
| 2016 | -0.52x | $-35.38 Million | $-48.17 Million | $68.37 Million | ▲ +23.1% |
| 2015 | -0.67x | $-27.63 Million | $-32.74 Million | $41.07 Million | ▼ 0.0% |
| 2014 | -0.67x | $-27.63 Million | $-32.74 Million | $41.07 Million | ▼ -192.4% |
| 2013 | 0.73x | $38.68 Million | $37.23 Million | $53.11 Million | ▲ +138.0% |
| 2012 | -1.92x | $-7.61 Million | $-7.77 Million | $3.97 Million | — |